Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Intra-oral snoring devices may be acceptable for OTC sale -- FDA Dental Products Panel.

This article was originally published in The Tan Sheet

Executive Summary

INTRA-ORAL SNORING DEVICES OTC AVAILABILITY MAY BE ACCEPTABLE with appropriate safety and efficacy data, members of FDA's Dental Products Panel said at a Nov. 5 meeting in Bethesda, Md. Responding to FDA's request for general input on the possibility of over-the-counter sale of intra-oral devices for treatment of snoring and sleep apnea, most panel members felt OTC labeling for treatment of snoring, but not sleep apnea, might be conceivable.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel